Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Jul 9;4(2):651.
doi: 10.4081/cp.2014.651. eCollection 2014 Jun 18.

Feminizing Adrenocortical Carcinoma with Distant Metastases: Can Surgery be Considered?

Affiliations
Case Reports

Feminizing Adrenocortical Carcinoma with Distant Metastases: Can Surgery be Considered?

Alessandro Fancellu et al. Clin Pract. .

Abstract

Functioning adrenocortical carcinomas are rare diseases with dismal prognosis. A 41-year-old man presenting with gynecomastia had a giant feminizing adrenocortical carcinoma at stage IV. Although surgical resection was controversial, we removed the primary tumor to reduce the mass effects. He lived for 12 months with an acceptable quality of life. Gynecomastia may be the first sign of feminizing adrenal malignancies. Surgery may ameliorate the quality of life in selected patients with metastatic disease.

Keywords: Adrenocortical carcinoma; feminizing; gynecomastia; rare tumor; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare no potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Computed tomographic scan of the abdomen revealed a large tumor of the left adrenal (25 cm in its maximum diameter) with colliquative areas, occupying almost entirely the hemiabdomen.
Figure 2.
Figure 2.
The adrenal mass measured 25×17 cm, and appeared encapsulated, yellowish with extensive areas of necrosis and mucoid degeneration, encompassing the left kidney (black arrow).
Figure 3.
Figure 3.
Histological examination with standard hematoxylin and eosin showing a proliferation of large epithelial cells and pleomorphic oxyphil nuclei (A, 200×; B, 400×), with large areas of necrosis and endovascular embolization (C, 100×; D, 200×). Immunohistochemistry showing strong positivity for Melan-A and Synaptophysin in the tumor cells (E, 200×; F, 200×).

References

    1. Kidd MT, Karlin NJ, Cook CB. Feminizing adrenal neoplasms: case presentations and review of the literature. J Clin Oncol 2011;29:e127-30 - PubMed
    1. Lafemina J, Brennan MF. Adrenocortical carcinoma: past, present, and future. J Surg Oncol 2012;106:586-94 - PubMed
    1. Patalano A, Brancato V, Mantero F. Adrenocortical cancer treatment. Horm Res 2009;71:99-104 - PubMed
    1. Lerario AM, Moraitis A, Hammer GD. Genetics and epigenetics of adrenocortical tumors. Mol Cell Endocrinol 2014; 386:67-84 - PMC - PubMed
    1. Advani A, Johnson SJ, Nicol MR, Papacleovoulou G, et al. . Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma. Endocr J 2010;57:651-6 - PubMed

Publication types